165 related articles for article (PubMed ID: 3891282)
1. Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitor.
Smith BR; LeFrock JL
Drug Intell Clin Pharm; 1985 Jun; 19(6):415-20. PubMed ID: 3891282
[TBL] [Abstract][Full Text] [Related]
2. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
Stein GE; Gurwith MJ
Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
[TBL] [Abstract][Full Text] [Related]
3. Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects.
Weber DJ; Tolkoff-Rubin NE; Rubin RH
Pharmacotherapy; 1984; 4(3):122-36. PubMed ID: 6739312
[TBL] [Abstract][Full Text] [Related]
4. Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.
Parker RH; Eggleston M
Infect Control; 1987 Jan; 8(1):36-40. PubMed ID: 3028975
[TBL] [Abstract][Full Text] [Related]
5. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the field of otorhinolaryngology].
Kawamura S; Sugita R; Fujimaki Y; Deguchi K
Jpn J Antibiot; 1983 Mar; 36(3):500-8. PubMed ID: 6553606
[TBL] [Abstract][Full Text] [Related]
6. beta-Lactamase inhibitors.
Conner CS
Drug Intell Clin Pharm; 1985 Jun; 19(6):475-6. PubMed ID: 2988903
[TBL] [Abstract][Full Text] [Related]
7. Amoxicillin-clavulanic acid in the treatment of lower respiratory tract infections caused by beta-lactamase-positive Haemophilus influenzae and Branhamella catarrhalis.
Wallace RJ; Steele LC; Brooks DL; Luman JI; Wilson RW; McLarty JW
Antimicrob Agents Chemother; 1985 Jun; 27(6):912-5. PubMed ID: 3875310
[TBL] [Abstract][Full Text] [Related]
8. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1985 Feb; 38(2):342-58. PubMed ID: 3847522
[TBL] [Abstract][Full Text] [Related]
9. Amoxicillin-clavulanic acid (Augmentin).
Med Lett Drugs Ther; 1984 Nov; 26(674):99-100. PubMed ID: 6387417
[No Abstract] [Full Text] [Related]
10. Clavulanate-potentiated amoxycillin: activity in vitro and bioavailability in the dog.
Bywater RJ; Palmer GH; Buswell JF; Stanton A
Vet Rec; 1985 Jan; 116(2):33-6. PubMed ID: 3871985
[TBL] [Abstract][Full Text] [Related]
11. Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis.
Maesen FP; Davies BI; Baur C
J Antimicrob Chemother; 1987 Mar; 19(3):373-83. PubMed ID: 3494724
[TBL] [Abstract][Full Text] [Related]
12. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
Mashimo K
Jpn J Antibiot; 1985 Aug; 38(8):2011-25. PubMed ID: 3908731
[No Abstract] [Full Text] [Related]
13. [Experimental and clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
Jpn J Antibiot; 1985 Feb; 38(2):481-506. PubMed ID: 3892076
[TBL] [Abstract][Full Text] [Related]
14. Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.
Brogden RN; Carmine A; Heel RC; Morley PA; Speight TM; Avery GS
Drugs; 1981 Nov; 22(5):337-62. PubMed ID: 7037354
[TBL] [Abstract][Full Text] [Related]
15. Amoxicillin-clavulanate (Clavulin). Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
Infectious Diseases and Immunization Committee
CMAJ; 1985 Oct; 133(8):739. PubMed ID: 4042055
[No Abstract] [Full Text] [Related]
16. [Clinical study of BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
Nagamatsu I; Horiguchi S; Hatae T
Jpn J Antibiot; 1985 Feb; 38(2):287-95. PubMed ID: 3847518
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) in the fields of obstetrics and gynecology].
Kishida H; Kisaka Y; Matsubayashi S; Hiraoka H; Naitoh H; Tanaka S; Urabe T; Fujiwara A
Jpn J Antibiot; 1983 Mar; 36(3):487-99. PubMed ID: 6553605
[TBL] [Abstract][Full Text] [Related]
18. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
Hoshina H; Hirosawa H; Mikuni K; Ichihashi H
Jpn J Antibiot; 1985 Feb; 38(2):309-18. PubMed ID: 3847520
[TBL] [Abstract][Full Text] [Related]
19. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Nakazawa S; Sato H; Narita A; Matsumoto K; Nakazawa S; Suzuki H; Chikaoka H; Tazoe K; Nakada Y; Niino K
Jpn J Antibiot; 1985 Feb; 38(2):296-308. PubMed ID: 3847519
[TBL] [Abstract][Full Text] [Related]
20. [Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Nishimura T; Tabuki K; Takashima T; Takagi M
Jpn J Antibiot; 1985 Feb; 38(2):431-40. PubMed ID: 4009952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
